Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
I'm hopeful for SGMO zinc fingers tech for genetic therapies.

As you have noted, BLUE lentiglobin tech is doing well. Last I checked in with them they were doing well on hemophilia and thalassemia trials.

CRISPR seems like it has reputation / too high a risk of off-target modifications.

Allogenic off the shelf therapy is a dream and worth pursuing but seems very far off based on these results.

No position in any of these right now.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.